2024 MCM | Colorectal Cancer: Incorporating Molecular Testing and Checkpoint Inhibitors to the Standard of Care

2024 MCM | Colorectal Cancer: Incorporating Molecular Testing and Checkpoint Inhibitors to the Standard of Care

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Cathy Eng, MD

Date of Release

May 14th, 2025